Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Comparative effectiveness research with established therapies would help determine the relative benefits and risks of these peptides compared to current standard treatments and would inform evidence-based treatment decisions
10.1016/j.intimp.2011.12.004 61 IidaK.ItohK.KumagaiY.OyasuR.HattoriK.KawaiK.et al (2004)
The combination has one preclinical synergy paper but no human trial data of its own
Once the sequence was known and recombinant expression became routine, native-sequence human IGF-1 became available as a laboratory reagent and, separately, as a licensed protein under the name mecasermin
US$ 28.41
US$ 28.94
US$ 21.06
US$ 25.02
US$ 24.75
